インフリキシマブ投与中止後の寛解維持に関するブシラミン研究

基本情報

NCT ID

NCT00716248

ステータス

不明

試験のフェーズ

第4相

試験タイプ

介入

目標被験者数

40

治験依頼者名

Saitama Medical University

概要

Patients with rheumatoid arthritis who have been well controlled with methotrexate plus infliximab may remain in remission or low disease activity without infliximab. And the chance of sustained remission increase by the addition of another DMARD, bucillamine, at the time of discontinuing infliximab. The BuSHIDO trial is the prospective, randomized, controlled study comparing MTX monotherapy and MTX plus bucillamine combination therapy as to the rate of disease flare after discontinuing infliximab.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)